Team:Paris Bettencourt/YonatanTest

From 2013.igem.org

(Difference between revisions)
Line 68: Line 68:
<div class="biocriks">
<div class="biocriks">
-
  <center> <img width="95%" src="https://static.igem.org/mediawiki/2013/5/55/PB_Bb_target.png"/><br></center>
+
  <center> <img width="95%" style="margin-top:30px" src="https://static.igem.org/mediawiki/2013/5/55/PB_Bb_target.png"/><br></center>
 
 
</div>
</div>
Line 74: Line 74:
       <div class="mainfig">
       <div class="mainfig">
         <center> <img height="60%" src="https://static.igem.org/mediawiki/2013/9/99/PB_fig_target.png"/></center>
         <center> <img height="60%" src="https://static.igem.org/mediawiki/2013/9/99/PB_fig_target.png"/></center>
-
         <p style="margin-top:-60px;font-size:14px">CRISPR anti-Kan plasmids target kanamycin resistant E. coli. WT (blue bars) and a kanamycin resistant strain (KanR, red bars) were co-transformed with a plasmid carrying the Cas9 construct, and a second plasmid carrying the anti-Kanamycin gRNA. WT E. coli was transformed with one and both plasmids.  KanR E. coli couldn’t be tranformed with both plasmids because of Cas9-induced cleavage of the chromosome specifically at the KanR cassette, with about 99% efficiency.
+
         <p style="margin-top:-60px;font-size:13px">CRISPR anti-Kan plasmids target kanamycin resistant E. coli. WT (blue) and a kanamycin resistant strain (KanR, red) were co-transformed with a plasmid carrying the Cas9 construct, and a second plasmid carrying the anti-Kanamycin gRNA. WT was successfully transformed with one or both plasmids.  KanR E. coli couldn’t be tranformed with both plasmids because of Cas9-induced cleavage of the chromosome specifically at the KanR cassette, with about 99% efficiency.
</p>
</p>
       </div>
       </div>

Revision as of 12:12, 25 October 2013

Detect

Background

CRISPR/Cas systems generate site-specific double strand breaks and have recently been used for genome editing.

Aims

Building a genotype sensor based on CRISPR/Cas that reports existance of an antibiotic resistance gene.

Results

  • Successfully cloned gRNA anti-KAN, crRNA anti-KAN, tracrRNA-Cas9 and pRecA-LacZ into Biobrick backbones and therefore generated four new BioBricks.
  • Testing the new assembly standard for our cloning.

CRISPR anti-Kan plasmids target kanamycin resistant E. coli. WT (blue) and a kanamycin resistant strain (KanR, red) were co-transformed with a plasmid carrying the Cas9 construct, and a second plasmid carrying the anti-Kanamycin gRNA. WT was successfully transformed with one or both plasmids. KanR E. coli couldn’t be tranformed with both plasmids because of Cas9-induced cleavage of the chromosome specifically at the KanR cassette, with about 99% efficiency.

Centre for Research and Interdisciplinarity (CRI)
Faculty of Medicine Cochin Port-Royal, South wing, 2nd floor
Paris Descartes University
24, rue du Faubourg Saint Jacques
75014 Paris, France
+33 1 44 41 25 22/25
team2013@igem-paris.org
Hit Counter by Digits
Copyright (c) 2013 igem.org. All rights reserved.